Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon May 25, 2020 5:01pm
99 Views
Post# 31070538

RE:RE:Facts are money is not a problem + riplazym partnership is

RE:RE:Facts are money is not a problem + riplazym partnership isWhat was the indication 4050 was being trialed over in England.  

Silence on that one for the last nine months.  Just like all the others mentioned in that article so so long ago.  Add another to the list of failures.

How many shares has Senior Exec and Board Members purchased since the reverse split of 1000 for one?  Should tell you alot about where this is going.
<< Previous
Bullboard Posts
Next >>